City of Hope in Duarte, California, recently announced that its subsidiary, Cancer Treatment Centers of America (CTCA), will fully transition its clinical locations to City of Hope’s brand. CTCA locations in different cities will now be called City of Hope Atlanta, City of Hope Chicago, and City of Hope Phoenix. In addition to the replacement of CTCA branding at clinical facilities, all marketing, advertising, communications, and activities supporting these locations will reflect City of Hope’s name.
The move comes as City of Hope approaches the 1-year anniversary of its acquisition of CTCA and further solidifies its transformation into a national cancer research and treatment system with locations across the country. Other integration milestones include CTCA locations now functioning as nonprofit organizations, the ongoing implementation of City of Hope clinical and quality policies across all locations, and joint quality reviews and tumor boards in which national experts provide education and insight on complex cases to provide the best care across all locations. City of Hope has also brought its expertise in bone marrow and blood stem cell transplantations and chimeric antigen receptor T-cell therapy to CTCA Phoenix and CTCA Chicago. With the integration of CTCA’s well-established and geographically broad clinical network, City of Hope accelerates its ability to increase community-based access to the most advanced treatments, including its hematology/bone marrow transplantation programs, clinical trials, and advanced precision medicine and cellular therapies.
Leadership Reorganization
City of Hope has reorganized its leadership structure to help accelerate and more broadly export the organization’s innovative cancer treatment and care. As part of this process, it was recently announced that Kevin Manemann will join City of Hope as Executive Vice President and Chief Integration Officer for the clinical enterprise. In this newly created role, Mr. Manemann will lead clinical enterprise integration initiatives across City of Hope, with a focus on patient access, strategic program development, and system integration at the regional and national levels. Mr. Manemann joins City of Hope after 20 years with Providence St. Joseph Health, where he most recently served as Chief Executive of the southern division.
Mr. Manemann is part of several recent leadership hires reflecting City of Hope’s evolution into a national system, including the naming of Jo Ann Escasa-Haigh as City of Hope’s Chief Business Officer. As part of her role, Ms. Escasa-Haigh will have direct oversight of City of Hope’s financial strategy, mergers, and acquisitions; finance operations; and managed care. In September 2022, Philip Okala joined City of Hope as System President, with oversight responsibilities for the organization’s portfolio of clinical care and research entities. These new system roles are responsible for setting and aligning the organization’s strategic direction with its mission and vision; ensuring consistency and coordination across all City of Hope entities; and enabling the best patient, research, and administrative outcomes.
